Genkyotex
Drug development platform targeting NOX enzymes to prevent oxygen radical production.
4
Funding Rounds
$51.8m
Money raised
Overview
Drug development platform targeting NOX enzymes to prevent oxygen radical production.
- Business model: B2B
- Headquarters: Geneva
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Genkyotex has raised a total of $51.77m in funding over 4 rounds.
Key Insights:
- GenKyoTex Series C round, July 2012: $26m
- GenKyoTex Series C round, May 2011: $20.4m
- GenKyoTex funding round, May 2008: $3.82m
- GenKyoTex funding round, January 2006: $1.55m
GenKyoTex Series C round, July 2012
$26m
GenKyoTex Series C round, May 2011
$20.4m
GenKyoTex funding round, May 2008
$3.82m
GenKyoTex funding round, January 2006
$1.55m
Industries
Genkyotex is active in the following industries: